Home›People›David Sable
David Sable

David Sable

Business and Clinical Advisor, Board of Directors at AutoIVF.

Director
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About David Sable

David Sable is a business and clinical advisor, board of directors at AutoIVF.

Experience

This experience comes from David Sable's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Sable in the role, so the role may have started earlier or lasted longer.

AutoIVF, Inc. Current
Business and Clinical Advisor, Board of Directors
2024 – Present · Natick, MA
AutoIVF develops automated egg preparation equipment for IVF laboratories.
Evvy Current
Advisory Board Member
2024 – Present
Conceivable Life Sciences Current
Advisory Board Member
2023 – Present
Celmatix Current
Director
2019 – Present
TMRW Life Sciences, Inc. Current
Board observer and SAB member
2018 – Present
Life Sciences Current
Portfolio Manager
2005 – Present
Columbia University
Instructor
2011 – 2025
Hamilton Thorne, Inc.
Director
2011 – 2024
MedAnswers
Director
2019 – 2022
Ohana Biosciences, Inc.
Director
2020 – 2021
Forbes
Contributor
2014 – 2020
RESOLVE: The National Infertility Association
Board Member
2012 – 2017
Deutsche Bank
Healthcare analyst, Equitech Group
2004 – 2005
Saint Barnabas Health Care System
Director, Division of Reproductive Endocrinology
1992 – 2004
Brigham and Women's Hospital
Fellow, Division of Reproductive Endocrinology
1990 – 1992
New York Presbyterian Hospital
Resident, Department of Obstetrics and Gynecology
1986 – 1990

Key Colleagues at Startups

The people David Sable works with at each company, as listed on that company's latest Form D.

AutoIVF, Inc. · Form D, Sep 25, 2026
Erin Schardt
Erin Schardt
Board of Directors
Michael Alper
Michael Alper
Clinical Advisor, Board of Directors
Ravi Kapur
Ravi Kapur
Chief Executive Officer, Board of Directors
Mitchell Sayare
Mitchell Sayare
Business Advisor, Chairman, Board of Directors

Sources

  1. SECAutoIVF, Inc. Form D, filed Sep 25, 2026